A systematic review and meta-analysis of familial prostate cancer risk

被引:199
作者
Johns, LE [1 ]
Houlston, RS [1 ]
机构
[1] Inst Canc Res, Sect Canc Genet, Sutton SM2 5NG, Surrey, England
关键词
prostate cancer; familial risk; meta-analysis;
D O I
10.1046/j.1464-410X.2003.04232.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
To identify published studies quantifying familial prostate cancer risks in relatives of prostate cancer cases and, by meta-analysis, obtain more precise estimates of familial risk according to the family history. Thirteen case-control and cohort studies were identified which have reported risks of prostate cancer in relatives of prostate cancer cases. Pooled estimates of risk for various categories of family history were obtained by calculating the weighted average of the log relative risk (RR) estimates from studies. The pooled RR (95% confidence interval) in first-degree relatives was 2.5 (2.2-2.8). There was evidence that this was highest in relatives of cases diagnosed before age 60 years and that RRs declined with age. The risk for the few men with two affected relatives was increased 3.5-fold (2.6-4.8). RRs to sons of cases appeared to be lower than in brothers; a complete explanation of this observation is uncertain. Men with a family history of prostate cancer have a significantly greater risk of developing prostate cancer than those with no such history. Risks are greatest for relatives of cases diagnosed when young and those with more than one relative affected.
引用
收藏
页码:789 / 794
页数:6
相关论文
共 57 条
[1]  
[Anonymous], 1982, Cancer Surv
[2]  
[Anonymous], 1987, STAT METHODS CANC RE
[3]   Significance of familial history of prostate cancer to traditional prognostic variables, genetic biomarkers, and recurrence after radical prostatectomy [J].
Bauer, JJ ;
Srivastava, S ;
Connelly, RR ;
Sesterhenn, IA ;
Preston, DM ;
McLeod, DG ;
Moul, JW .
UROLOGY, 1998, 51 (06) :970-976
[4]   Analysis of the prostate cancer-susceptibility locus HPC20 in 172 families affected by prostate cancer [J].
Bock, CH ;
Cunningham, JM ;
McDonnell, SK ;
Schaid, DJ ;
Peterson, BJ ;
Pavlic, RJ ;
Schroeder, JJ ;
Klein, J ;
French, AJ ;
Marks, A ;
Thibodeau, SN ;
Lange, EM ;
Cooney, KA .
AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 68 (03) :795-801
[5]   Familial and hereditary prostate cancer in southern Sweden. A population-based case-control study [J].
Bratt, O ;
Kristoffersson, U ;
Lundgren, R ;
Olsson, H .
EUROPEAN JOURNAL OF CANCER, 1999, 35 (02) :272-277
[6]  
Breslow NE, 1987, STAT METHODS CANC RE, VII
[7]   PCAP is the major known prostate cancer predisposing locus in families from south and west Europe [J].
Cancel-Tassin, G ;
Latil, A ;
Valéri, A ;
Mangin, P ;
Fournier, G ;
Berthon, P ;
Cussenot, O .
EUROPEAN JOURNAL OF HUMAN GENETICS, 2001, 9 (02) :135-142
[8]   MENDELIAN INHERITANCE OF FAMILIAL PROSTATE-CANCER [J].
CARTER, BS ;
BEATY, TH ;
STEINBERG, GD ;
CHILDS, B ;
WALSH, PC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (08) :3367-3371
[9]   Segregation analyses of 1,476 population-based Australian families affected by prostate cancer [J].
Cui, JS ;
Staples, MP ;
Hopper, JL ;
English, DR ;
McCredie, MRE ;
Giles, GG .
AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 68 (05) :1207-1218
[10]   METAANALYSIS IN CLINICAL-TRIALS [J].
DERSIMONIAN, R ;
LAIRD, N .
CONTROLLED CLINICAL TRIALS, 1986, 7 (03) :177-188